New potent HBV replication inhibitors for the management of chronic hepatitis B are needed

Affiliations

• ¹ Baruch S. Blumberg Institute, Doylestown, PA, USA. tim.block@bblumberg.org.
• ² Baruch S. Blumberg Institute, Doylestown, PA, USA.
• ³ Viral Hepatitis Research Laboratory of INSERM Unit 1052, Hepatology Department, Hospices Civils de Lyon, University of Lyon, Lyon, France.
• ⁴ Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
• ⁵ Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
• ⁶ Department of Transfusion Medicine Clinical Center, The National Institutes of Health Bethesda, Bethesda, MD, USA.
• ⁷ Department of Medicine, NYU Langone Health, New York, NY, USA.
• ⁸ Hepatitis B Foundation, Doylestown, PA, USA.
• ⁹ Division of Gastroenterology and Hepatology, New York University Langone Hospital, New York, NY, USA.
• ¹⁰ Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada.